Hemostatic Agents Market - Forecast(2016 - 2022)
Hemostats are instruments used to reduce or halt bleeding during a surgery. These can be enabled by the use of smearing pressure, stitching the bleeding or using thermal energy devices. Hemostats generally are used to clot the blood during surgical procedures. Technical advancements have increased the usage of topical hemostatic agents in an extensive variety of surgical situations. Make it into a different sentence. New tissue sealants and hemostats in the market have addressed issue related to tissue contamination with previous sealants. How the new tissue sealants are addressing the previous sealant. New tissue sealants helps in reducing tissue contamination. Global hemostatic agents market is estimated to grow at a CAGR of 7.1% to reach $8,347.9m by 2022.

- Johnson & Johnson Services, Inc. (U.S.)
- Baxter International Incorporation (U.S.)
- C.R. Bard Incorporation (U.S.)
- B.Braun Melsungen AG (Germany)
- Advanced Medical Solutions Group (U.K.)
- 10+.
- We also publish more than 100 reports every month in “Lifesciences and Healthcare”, Go through the Domain if there are any other areas for which you would like to get a market research study.
Comments
Post a Comment